Globus Medical (GMED) Capital Expenditures (2011 - 2026)

Globus Medical (GMED) has reported Capital Expenditures for 16 consecutive years, with $33.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Capital Expenditures fell 28.77% year-over-year to $33.2 million; the trailing twelve-month figure through Jun 2026 stood at $154.8 million (up 9.22% YoY), and the FY2025 full-year result was $164.7 million, up 42.67% from the prior year.
• Capital Expenditures retreated to $33.2 million in Q2 2026 per GMED's latest filing, from $39.6 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $46.6 million in Q2 2025 and bottomed at $12.0 million in Q3 2022.
• Historically, Capital Expenditures has averaged $28.1 million across 5 years, with a median of $25.8 million in 2022.
• The widest YoY moves for Capital Expenditures: up 183.25% in 2022, down 32.66% in 2022.
• Over 5 years, Capital Expenditures stood at $18.3 million in 2022, then grew by 24.76% to $22.9 million in 2023, then fell by 25.22% to $17.1 million in 2024, then surged by 169.98% to $46.2 million in 2025, then decreased by 28.2% to $33.2 million in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $33.2 million, $39.6 million, and $46.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.